No Data
KAINOS Laboratories: Interim report - 50th period (2024/04/01 - 2024/09/30)
Hikari Tsushin increases its stake in KAINOS Laboratories(4556.JP) to 16.48%
On Nov 5, Hikari Tsushin and related parties submitted the Change Report to Ministry of Finance. The report shows that Hikari Tsushin and related parties increased their holdings in $KAINOS
KAINOS Laboratories: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)
Nomura Holdings, Shin-Etsu Chemical, Chugai Pharmaceutical, Hitachi Construction (25th)
※Please note that the above calendar is tentative and subject to change depending on the company's schedule. --------------------------------------- October 25th (gold) <2481> Town News <2664> Kawachi Chemicals <2790> Nafco <2804> Bulldog <3231> Nomura Real Estate HD <3912> Mobafac <4063> Shin-Etsu Chemical <4519> Chugai Pharmaceutical
No appointment (21st) [Financial schedule].
※The above calendar is just a plan and may be subject to change depending on the company's schedule. ---------------------------------------October 21 (Mon)---------------------------------------October 22 (Tue) <8218> Komeri <9278> Book Off GHD <9691> Ryokei System ---------------------
Shimizu Construction, Kitano Construction, and others [5% rule]
<1803> Shimizu Construction Co., Ltd. has a shareholding ratio of 5.20% in the social welfare corporation Shimizu Fund for Social Welfare. Reporting obligation date is 10 July 2024. <1866> Kitano Construction Co., Ltd. has a shareholding ratio of 5.76% in Mitsubishi UFJ Financial Group. Reporting obligation date is 22 July 2024. <2330> Foreside Evo Fund (Evo Fund) Co., Ltd. has a shareholding ratio of 13.18%. Reporting obligation date is not provided.
No Data
No Data